Mar 31, 2026 08:07AM Rigel publishes final ARROW trial data for pralsetinib in lung cancer

Mar 3, 2026 04:22PM Rigel Pharmaceuticals (RIGL) Tops Q4 EPS by 1354c

Jan 12, 2026 08:07AM Rigel reports Q4 revenue of $69.8 million, projects 2026 growth

Dec 23, 2025 10:00AM Why Jefferies sees these stocks as standout biotech plays in 2026

Nov 17, 2025 08:05AM Rigel publishes 5-year data on leukemia drug REZLIDHIA

Nov 5, 2025 03:45PM Jefferies Upgrades Rigel Pharmaceuticals (RIGL) to Buy, 'Strong Commercial Execution'

Nov 5, 2025 09:11AM Rigel Pharmaceuticals (RIGL) PT Raised to $69 at Citi

Nov 4, 2025 04:34PM Rigel Pharma (RIGL) Tops Q3 EPS by 146c

Oct 9, 2025 06:42AM H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)

Aug 6, 2025 05:45AM Rigel Pharmaceuticals (RIGL) PT Raised to $23 at Jefferies

May 22, 2025 05:21PM Rigel Pharma (RIGL) announces seven upcoming poster presentations at 2025 ASCO

May 7, 2025 05:11AM Rigel Pharmaceuticals (RIGL) PT Lowered to $20.45 at Jefferies

May 6, 2025 05:08PM Rigel Pharma (RIGL) Tops Q1 EPS by 63c

Mar 27, 2025 08:05AM Rigel Pharma (RIGL) Announces Settlement Agreement Resolving TAVALISSE Patent Litigation

Mar 10, 2025 08:07AM Rigel Pharma (RIGL) Appoints Mark W. Frohlich, M.D. to Board of Directors

Mar 6, 2025 05:06AM Rigel Pharmaceuticals (RIGL) PT Raised to $55 at Citi

Mar 5, 2025 07:07AM NeuroPace Inc (NPCE) PT Raised to $20 at Cantor Fitzgerald

Mar 5, 2025 07:05AM Cantor Fitzgerald Reiterates Neutral Rating on Rigel Pharmaceuticals (RIGL)

Mar 5, 2025 06:51AM H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)

Mar 4, 2025 04:27PM Rigel Pharma (RIGL) Tops Q4 EPS by 80c

Jan 22, 2025 08:05AM Rigel Pharma's (RIGL) Fostamatinib Studied by National Institute of Health in Patients with Sickle Cell Disease

Jan 13, 2025 08:05AM Rigel Pharma (RIGL) Provides Business Update and 2025 Outlook

Dec 9, 2024 12:02PM Rigel Pharma (RIGL) Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and Exposition

Dec 2, 2024 08:05AM Rigel Pharma (RIGL) Announces R289 Granted FDA Fast Track Designation

Nov 11, 2024 06:59AM Rigel Pharmaceuticals (RIGL) PT Raised to $49 at Citi

Oct 24, 2024 04:36PM Rigel Pharma (RIGL) Issues Dear Healthcare Provider Letter for GAVRETO

Oct 16, 2024 10:01AM Rigel Pharma (RIGL) and Optime Care Expands Partnership to Include Commercial Distribution for TAVALISSE

Sep 6, 2024 06:55AM H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)

Sep 3, 2024 09:36AM H.C. Wainwright Reiterates Buy Rating on Rigel Pharmaceuticals (RIGL)

Sep 3, 2024 08:03AM Rigel Pharma (RIGL) Expands Relationship with Kissei to include REZLIDHIA in Japan, Korea and Taiwan

Aug 7, 2024 06:47AM Rigel Pharmaceuticals (RIGL) PT Raised to $57 at H.C. Wainwright

Aug 6, 2024 04:52PM Rigel Pharma (RIGL) Misses Q2 EPS by 4c

Jun 27, 2024 10:00AM Rigel Pharma (RIGL) and Optime Care Partner over GAVRETO Patients

Jun 25, 2024 08:01AM Rigel Pharma (RIGL) Announces Reverse Stock Split

Jun 24, 2024 04:07PM Rigel Pharma (RIGL) Completes Transfer of GAVRETO NDA